At GAIA we develop evidence-based, safe and accessible digital therapeutics that help patients restore and maintain mental and physical health. We combine clinical research, software engineering and regulatory expertise to bring medically validated digital treatments to market.

Our team includes physicians, psychotherapists, clinical scientists, IT engineers and regulatory and market-access specialists. Notable products include deprexis, an online program for depression studied in multiple randomized controlled trials with effect sizes comparable to antidepressants.

Headquartered in Hamburg, Germany, with a US office in New York. Contact: [email protected].